Close Menu

Grants

Additional funding opportunities

Research Funding Opportunities

Tools to Find Funding

Grants Awarded for Health Sciences Research

Title Type $ Amount Activity Investigator Unitsort descending Sponsor Date
Prescribing Vitamin D: An Exploratory Comparative Survey of University of Arizona Integrative Medicine Fellows' Attitudes and Practices Contract $101,919.00 Research Lisa Alschuler Andrew Weil Ctr Intgrtv Med Pharmavite 01/2020
Coronavirus Telehealth Resource Centers Grant $828,571.00 Other Sponsored Activity Ronald Weinstein Arizona Telemedicine Program Health Resources and Services Administration 06/2020
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 with Placebo and with Tofacitinib in Combination with Conventional Synthetic DMARDs.... Contract $314,050.00 Clinical Trial Chian Kwoh Arthritis Center-Research IQVIA RDS Inc. 03/2020
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Ifetroban in Patients with Diffuse Cutaneous Systemic Sclerosis or Systemic Sclerosis-Associated... Contract $55,928.00 Clinical Trial Chian Kwoh Arthritis Center-Research Cumberland Pharmaceuticals, Incorporated 07/2020
Binational Early Asthma & Microbiome Study (BEAMS) Grant $15,309,471.00 Research Fernando Martinez Asthma/Airway Disease Rsch Ctr National Institute of Allergy and Infectious Disease 08/2020
Epitope Open-Label Extension Study to Evaluate the Long-Term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX) Contract $173,290.72 Clinical Trial Heather Cassell Asthma/Airway Disease Rsch Ctr Pharmaceutical Research Associates 02/2020
A Phase 2, Double-Blind, Placebo-Controlled Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetic/Pharmacodynamic Relationships of Different Doses.... Contract $273,767.50 Clinical Trial Cori Daines Asthma/Airway Disease Rsch Ctr Janssen Research & Development, LLC 01/2020
Octapharma's Octagam 10% Gam10-09 Study Contract $64,944.00 Research Michael Daines Asthma/Airway Disease Rsch Ctr Octapharma Pharmazeutika Produktionsgesellschaft mbH (Austria) 08/2020
B Cell-Adaptive Immune Profile in Emphysema-Predominant COPD Grant $3,364,046.00 Research Francesca Polverino Asthma/Airway Disease Rsch Ctr National Heart, Lung, and Blood Institute 07/2020
Early Origins of Chronic Lung Disease: Outcomes into the Fifth Decade of Life Grant $6,030,330.00 Research Fernando Martinez Asthma/Airway Disease Rsch Ctr National Heart, Lung, and Blood Institute 04/2020
Beyond Pseudotime: Enhanced Single-cell GEnomics Tools for Understanding the Temporal Dynamics of Development and Disease Grant $1,822,950.00 Research Darren Cusanovich Asthma/Airway Disease Rsch Ctr National Institute of General Medical Sciences 08/2020
Area Health Education Centers Program COVID Grant $95,455.00 Instruction Daniel Derksen AZ Health Education Centers Health Resources and Services Administration 06/2020
Phase 1/1b Multicenter, Open-Label, First-in-Human Dose Escalation and Dose Expansion Study to Assess Safety and Tolerability of Orally Administered PMD-026 in Patients with Metastatic Breast Cancer w Contract $100,897.00 Clinical Trial Pavani Chalasani Cancer Center Division Phoenix Molecular Designs (Canada) 02/2020
SWOG NCORP Research Base Cooperative Agreement $54,000.00 Clinical Trial Daniel Persky Cancer Center Division Oregon Health and Science University 07/2020
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer Cooperative Agreement $64,679.91 Research Denise Roe Cancer Center Division Beckman Research Institute of The City of Hope 03/2020
A Phase 1 Open-Label, Multicenter Study to Evaluate Biomarkers for ZN-c5 in Subjects with Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Contract $91,617.50 Clinical Trial Pavani Chalasani Cancer Center Division Zeno Pharmaceuticals, Inc. 01/2020
A Phase 1, Open-label Study of ASP9801, an Oncolytic Virus, Administered by Intratumoral Injection in Patients with Advanced/Metastatic Solid Tumors Contract $458,027.74 Clinical Trial Hani Babiker Cancer Center Division Parexel International Corporation 01/2020
NRG Oncology NCORP Research Base Cooperative Agreement $144,704.00 Research Cynthia Thomson Cancer Center Division NRG Oncology 05/2020
Aberrant DNA Repair and Lupus Grant $6,175,318.00 Research Joann Sweasy Cancer Center Division National Institute of Environmental Health Sciences 07/2020
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate The Efficacy and Safety of Anamorelin HCL for the Treatment OF Malignancy Associated Weight Loss and Anorexia... Contract $42,626.00 Clinical Trial Charles Hsu Cancer Center Division PSI Pharma Support America, Incorporated 01/2020
Structure and Function of DNA Repair Enzymes and Cancer Grant $487,283.00 Research Joann Sweasy Cancer Center Division University of Vermont 03/2020
A Phase Ib/II Study of APG-115 in Combination with Pembrolizumab in Patients with Unresectable or Metastatic Melanomas or Advanced Solid Tumors Contract $513,891.00 Clinical Trial Montaser Shaheen Cancer Center Division Ascentage Pharma 01/2020
The Role of an MSH6 Gene Variant and UV Radiation in Systemic Lupus Erythematosus Grant $174,926.00 Research Rithy Meas Cancer Center Division National Institute of Environmental Health Sciences 08/2020
A Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Enzastaurin Plus R-CHOP Versus R-CHOP in Treatment-Naive Subjects with High-Risk Diffuse Large B-Cell Lymphoma Who Possess the Novel.. Contract $327,830.00 Clinical Trial Abhijeet Kumar Cancer Center Division Covance, Incorporated 01/2020
A Randomized Phase 3, Double-Blind Study of Chemotherapy With or Without Pembrolizumab Followed by Maintenance With Olaparib or Placebo for the First- Line Treatment of BRCA Non-Mutated Advanced... Contract $100,897.00 Clinical Trial Setsuko Chambers Cancer Center Division GOG Foundation, Inc. 08/2020

Pages